Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
10 Years of GWAS Discovery: Biology, Function, and Translation
Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., McCarthy, M. I., Brown, M. A., & Yang, J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.005 · Cited by 3,719
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00074.x · Cited by 1,772
“2 and SUR1, which form the KATP channel in pancreatic b-cells, have been identified [31, 32].”
BackgroundMahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Self-citationInwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles
Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., & Kurachi, Y. (2010) · Physiological Reviews · doi:10.1152/physrev.00021.2009 · Cited by 1,539
“2, which cause neonatal diabetes alone, directly impair ATP binding (16, 210, 211, 344, 629).”
BackgroundSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationDiabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902
Self-citationKATP channels as molecular sensors of cellular metabolism
Nichols, C. G. (2006) · Nature · doi:10.1038/nature04711 · Cited by 851
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Self-citationActivating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus
Babenko, A. P., Polak, M., Cavé, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., & Froguel, P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055068 · Cited by 655
The clinical utility of C‐peptide measurement in the care of patients with diabetes
Jones, A. G., & Hattersley, A. T. (2013) · Diabetic Medicine · doi:10.1111/dme.12159 · Cited by 628
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
ATP-sensitive potassium channelopathies: focus on insulin secretion
Ashcroft, F. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25495 · Cited by 623
Self-citationSeino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., Kasuga, M., et al. (2010) · Diabetology International · doi:10.1007/s13340-010-0006-7 · Cited by 614
In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism
Radford, E. J., Ito, M., Shi, H., Corish, J. A., Yamazawa, K., Isganaitis, E., Seisenberger, S., Hore, T. A., Reik, W., Erkek, S., et al. (2014) · Science · doi:10.1126/science.1255903 · Cited by 614
“These genes encode the two subunits of the pancreatic b-cell adenosine triphosphate (ATP)–dependent K channel, which are necessary for the physiological control of insulin secretion (34, 36).”
BackgroundGenome–wide association studies provide new insights into type 2 diabetes aetiology
Frayling, T. M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2178 · Cited by 594
Self-citationInsulin gene mutations as a cause of permanent neonatal diabetes
Støy, J., Edghill, E. L., Flanagan, S. E., Ye, H., Paz, V. P., Pluzhnikov, A., Below, J. E., Hayes, M. G., Cox, N. J., Lipkind, G. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707291104 · Cited by 564
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
Murphy, R., Ellard, S., & Hattersley, A. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0778 · Cited by 502
Self-citationFrom pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
“A gain-of-function mutation of this channel makes the β-cells more permeable to potassium, thereby making it difficult for the cells to be depolarized [104].”
BackgroundOsbak, K. K., Colclough, K., Saint-Martin, C., Beer, N. L., Bellanné-Chantelot, C., Ellard, S., & Gloyn, A. L. (2009) · Human Mutation · doi:10.1002/humu.21110 · Cited by 485
“Given the implications for prognosis, treatment decisions, and inheritance, it is important to identify individuals with GCK mutations [Gloyn and Ellard, 2006].”
BackgroundSelf-citationDefinition, epidemiology and classification of diabetes in children and adolescents
Craig, M. E., Hattersley, A., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00568.x · Cited by 461
Self-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Mutations in PTF1A cause pancreatic and cerebellar agenesis
Sellick, G. S., Barker, K. T., Stolte-Dijkstra, I., Fleischmann, C., J Coleman, R., Garrett, C., Gloyn, A. L., Edghill, E. L., Hattersley, A. T., Wellauer, P. K., et al. (2004) · Nature Genetics · doi:10.1038/ng1475 · Cited by 454
“2 subunit of the ATP-sensitive potassium pancreatic beta cell channel ( KCNJ11”
BackgroundSelf-citationMorán, I., Akerman, İ., van de Bunt, M., Xie, R., Benazra, M., Nammo, T., Arnes, L., Nakić, N., García-Hurtado, J., Rodríguez-Seguí, S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.010 · Cited by 447
“Islet antisense lncRNAs were found within loci underlying neonatal diabetes (ABCC8/KCNJ11), pancreas agenesis (GATA6), and monogenic diabetes (HNF1A) (Allen et al., 2012; Bell and Polonsky, 2001; Gloyn et al., 2004).”
Self-citationPearson, E. R., Boj, S. F., Steele, A. M., Barrett, T., Stals, K., Shield, J. P., Ellard, S., Ferrer, J., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 427
Self-citationUsing SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations
Flanagan, S. E., Patch, A.-M., & Ellard, S. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0036 · Cited by 418
“Loss-of-function mutations in the ABCC8 and KCNJ11 genes that encode the ATP-sensitive Kþ channel (KATP) in the pancreatic beta cell cause congenital hyperinsulinism, whereas gain-of-function mutations cause the opposing phenotype of diabetes (Thomas et al., 1995, 1996; Gloyn et al., 2004; Proks et al., 2006).”
Self-citationActivating Mutations in Kir6.2 and Neonatal Diabetes
Hattersley, A. T., & Ashcroft, F. M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2503 · Cited by 414
Self-citationPancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Wang, Z., York, N. W., Nichols, C. G., & Remedi, M. S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.010 · Cited by 406
“These findings thus reiterate key features of human neonatal diabetes resulting from severe KATP-GOFmutations (Flanagan et al., 2009; Gloyn et al., 2004; Matthews et al., 1998; Nolan et al., 2011; Pearson et al., 2006; Shimomura et al., 2007), as well as the consequences of KATP-GOF that result from the type 2 diabete…”
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0022 · Cited by 400
Self-citationInsulin Mutation Screening in 1,044 Patients With Diabetes
Edghill, E. L., Flanagan, S. E., Patch, A.-M., Boustred, C., Parrish, A., Shields, B., Shepherd, M. H., Hussain, K., Kapoor, R. R., Malecki, M., et al. (2008) · Diabetes · doi:10.2337/db07-1405 · Cited by 397
“2 and SUR1 subunits of the ATPsensitive potassium (KATP) channel are the commonest causes of PNDM (5-9).”
BackgroundSelf-citationLevin, M. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-12-0708 · Cited by 372
the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Gaulton, K. J., Ferreira, T., Lee, Y., Raimondo, A., Mägi, R., Reschen, M. E., Mahajan, A., Locke, A., William Rayner, N., et al. (2015) · Nature Genetics · doi:10.1038/ng.3437 · Cited by 398
Pharmacogenomics: current status and future perspectives
Pirmohamed, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00572-8 · Cited by 351
Dimas, A. S., Lagou, V., Barker, A., Knowles, J. W., Mägi, R., Hivert, M.-F., Benazzo, A., Rybin, D., Jackson, A. U., Stringham, H. M., et al. (2014) · Diabetes · doi:10.2337/db13-0949 · Cited by 366
Genome-wide association studies: potential next steps on a genetic journey
McCarthy, M. I., & Hirschhorn, J. N. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn289 · Cited by 359
“Allelic heterogeneity is a common feature of Mendelian disease, and many genes have been implicated in both rare and common forms of the same condition [one obvious example is KCNJ11 variants in which are related to diabetes phenotypes ranging from syndromic neonatal diabetes to common type 2 diabetes (69,70)].”
BackgroundDe Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Self-citationPermanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2
Sagen, J. V., Ræder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Bævre, H., Abuelo, D., Phornphutkul, C., Molnes, J., Bell, G. I., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2713 · Cited by 333
“DISCUSSION Recently, it has been shown (9) that PND can result from mutations in Kir6.”
BackgroundResultInfluentialSelf-citationDiabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Self-citationHuman genetics illuminates the paths to metabolic disease
O’Rahilly, S. (2009) · Nature · doi:10.1038/nature08532 · Cited by 324
Hattersley, A. T., Greeley, S. A. W., Polak, M., Rubio-Cabezas, O., Njølstad, P. R., Mlynarski, W., Castano, L., Carlsson, A., Raile, K., Chi, D. V., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12772 · Cited by 319
“Approximately half will require lifelong treatment to control hyperglycemia-permanent neonatal diabetes mellitus (PNDM).”
InfluentialSelf-citationThe metabolic basis of epilepsy
Rho, J. M., & Boison, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00651-8 · Cited by 295
The Emerging Genetic Architecture of Type 2 Diabetes
Doria, A., Patti, M.-E., & Kahn, C. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.006 · Cited by 305
“2/KCNJ11) in infants with neonatal diabetes has been very important, allowing these children to be treated with oral sulfonylureas rather than lifelong insulin injections (Gloyn et al., 2004; Pearson et al., 2006).”
BackgroundFlorez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 293
“In a research path that retraced the steps of the one travelled by the MODY genes, mutations that have a more potent effect on channel activation have been recently implicated in a subtype of permanent neonatal diabetes [ 51 ].”
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
“In some cases, understanding the basis for a monogenic disease can inform and rationalize drug therapy; thus, mutations in KCNJ11, a component of a sulfonylurea-sensitive potassium channel, cause neonatal diabetes that is especially sensitive to sulfonylureas (54, 55).”
BackgroundZhang, W., Feng, D., Li, Y., Iida, K., McGrath, B., & Cavener, D. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.002 · Cited by 285
Kubo, Y., Adelman, J. P., Clapham, D. E., Jan, L. Y., Karschin, A., Kurachi, Y., Lazdunski, M., Nichols, C. G., Seino, S., & Vandenberg, C. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.11 · Cited by 279
KATP channels and islet hormone secretion: new insights and controversies
Ashcroft, F. M., & Rorsman, P. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.166 · Cited by 272
Self-citationRafiq, M., Flanagan, S. E., Patch, A.-M., Shields, B. M., Ellard, S., Hattersley, A. T., & The Neonatal Diabetes International Collaborative Group (2008) · Diabetes Care · doi:10.2337/dc07-1785 · Cited by 265
Self-citationBarroso, I. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01550.x · Cited by 268
Muscle KATPChannels: Recent Insights to Energy Sensing and Myoprotection
Flagg, T. P., Enkvetchakul, D., Koster, J. C., & Nichols, C. G. (2010) · Physiological Reviews · doi:10.1152/physrev.00027.2009 · Cited by 263
“KATP in glucose-dependent insulin secretion (126, 221, 379), no consistent picture has yet emerged of human”
Reversible changes in pancreatic islet structure and function produced by elevated blood glucose
Brereton, M. F., Iberl, M., Shimomura, K., Zhang, Q., Adriaenssens, A. E., Proks, P., Spiliotis, I. I., Dace, W., Mattis, K. K., Ramracheya, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5639 · Cited by 259
Self-citationThe diagnosis and management of monogenic diabetes in children and adolescents
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00571.x · Cited by 255
“Kir6.2 mutations are the second commonest cause of mutations in patients with diabetes diagnosed in the first 6 months of life (B) ( 17 , 18).”
BackgroundInfluentialSelf-citationType 2 diabetes: new genes, new understanding
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.09.004 · Cited by 254
Groves, C. J., Zeggini, E., Minton, J., Frayling, T. M., Weedon, M. N., Rayner, N. W., Hitman, G. A., Walker, M., Wiltshire, S., Hattersley, A. T., et al. (2006) · Diabetes · doi:10.2337/db06-0355 · Cited by 252
“Seventh, despite indications that the known functions of TCF7L2 point toward loss of -cell function (rather than insulin action) as the anticipated consequence of gene disruption, we find no evidence that mutations within the coding regions of this gene are responsible for the -cell phenotype of permanent neonatal or…”
BackgroundSelf-citationAguilar-Bryan, L., & Bryan, J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0029 · Cited by 250
“(191) described the properties of KATP channels with the R201H mutation and confirmed an earlier report FIG.”
BackgroundResultFlanagan, S. E., Clauin, S., Bellanné-Chantelot, C., de Lonlay, P., Harries, L. W., Gloyn, A. L., & Ellard, S. (2009) · Human Mutation · doi:10.1002/humu.20838 · Cited by 241
Self-citationReduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes
Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., et al. (2012) · Diabetes · doi:10.2337/db11-1516 · Cited by 237
“Activating mutations in KCNJ11 are a cause of neonatal diabetes (23), and the nonsynonymous rs5219 risk allele of the channel (E23K) combined with the S1369A risk allele of the neighboring ABCC8 (encoding the sulfonylurea receptor 1) exhibits decreased ATP inhibition (24).”
BackgroundSelf-citationGenome-wide association studies in type 2 diabetes
McCarthy, M. I., & Zeggini, E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0027-4 · Cited by 233
“But what about using genetic information to improve treatment of diabetes at the level of the individual patient? Prescribing on the basis of personal molecular diagnosis is already established practice for those with monogenic forms of diabetes (eg, sulfonylureas for those with neonatal diabetes due to KCNJ11 mutatio…”
BackgroundGene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study
Langenberg, C., Sharp, S. J., Franks, P. W., Scott, R. A., Deloukas, P., Forouhi, N. G., Froguel, P., Groop, L. C., Hansen, T., Palla, L., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001647 · Cited by 237
“The clinical benefit of personalised pharmacological interventions has successfully been demonstrated for patients with rare, monogenic forms of diabetes [32,33], yet it is unknown whether Figure 3.”
Colombo, C., Porzio, O., Liu, M., Massa, O., Vasta, M., Salardi, S., Beccaria, L., Monciotti, C., Toni, S., Pedersen, O., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33777 · Cited by 234
Proks, P., Antcliff, J. F., Lippiat, J., Gloyn, A. L., Hattersley, A. T., & Ashcroft, F. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404756101 · Cited by 234
Self-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“evaluation of monogenic diabetes with therapeutic and prognostic implications (2-6).”
BackgroundFlanagan, S. E., Edghill, E. L., Gloyn, A. L., Ellard, S., & Hattersley, A. T. (2006) · Diabetologia · doi:10.1007/s00125-006-0246-z · Cited by 227
“The prevalence of diabetes due to a mutation in KCNJ11 is uncertain, with studies reporting mutations in between 34 and 64% of patients with permanent neonatal diabetes [ 1 , 4, 6, 10].”
BackgroundResultInfluentialSelf-citationZhang, Q., Ramracheya, R., Lahmann, C., Tarasov, A., Bengtsson, M., Braha, O., Braun, M., Brereton, M., Collins, S., Galvanovskis, J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.014 · Cited by 225
“The question then arises as to whether gain-of-function mutations found in patients with neonatal diabetes (Gloyn et al., 2004) affect glucagon secretion.”
BackgroundSelf-citationEllard, S., Flanagan, S. E., Girard, C. A., Patch, A.-M., Harries, L. W., Parrish, A., Edghill, E. L., Mackay, D. J. G., Proks, P., Shimomura, K., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519174 · Cited by 215
Self-citationGreeley, S. A. W., Polak, M., Njølstad, P. R., Barbetti, F., Williams, R., Castano, L., Raile, K., Chi, D. V., Habeb, A., Hattersley, A. T., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13426 · Cited by 211
“uals may harbor dominant mutations arising de novo; in such cases, a family history suggesting a monogenic condition is lacking.(41,90,139)”
BackgroundSelf-citationRecessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis
Garin, I., Edghill, E. L., Akerman, I., Rubio-Cabezas, O., Rica, I., Locke, J. M., Maestro, M. A., Alshaikh, A., Bundak, R., del Castillo, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910533107 · Cited by 211
“2 (4) and SUR1 (5–7), or heterozygous mutations in the preproinsulin (INS) gene (8–12).”
BackgroundSelf-citationProks, P., Arnold, A. L., Bruining, J., Girard, C., Flanagan, S. E., Larkin, B., Colclough, K., Hattersley, A. T., Ashcroft, F. M., & Ellard, S. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl101 · Cited by 211
“The main symptoms are developmental delay, muscle weakness, facial dysmorphism and epilepsy (4,8,20), a spectrum of symptoms that have been referred to as DEND syndrome (Developmental delay, Epilepsy and Neonatal Diabetes) (11).”
BackgroundSelf-citationGao, P., Yee, R., Gula, L., Krahn, A. D., Skanes, A., Leong-Sit, P., Klein, G. J., Stirrat, J., Fine, N., Pallaveshi, L., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.111.971549 · Cited by 212
Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes
Molven, A., Ringdal, M., Nordbø, A. M., Ræder, H., Støy, J., Lipkind, G. M., Steiner, D. F., Philipson, L. H., Bergmann, I., Aarskog, D., et al. (2008) · Diabetes · doi:10.2337/db07-1467 · Cited by 209
“olecular genetic studies of monogenic forms of diabetes such as MODY and neonatal diabetes have provided important insight into the pathophysiology and led to improved diagnosis and treatment (1-7).”
BackgroundSelf-citationPinney, S. E., MacMullen, C., Becker, S., Lin, Y.-W., Hanna, C., Thornton, P., Ganguly, A., Shyng, S.-L., & Stanley, C. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35414 · Cited by 202
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05181-w · Cited by 203
Self-citationIon channels: Function unravelled by dysfunction
Jentsch, T. J., Hübner, C. A., & Fuhrmann, J. C. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1039 · Cited by 201
Lemelman, M. B., Letourneau, L., & Greeley, S. A. W. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2017.10.006 · Cited by 193
Grarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014) · Diabetologia · doi:10.1007/s00125-014-3270-4 · Cited by 201
“Furthermore, de novo mutations have been shown to be a frequent cause of permanent neonatal diabetes and de novo mutations in HNF1B is a cause of MODY5 [77, 142]; however, discovery of de novo risk variants is most likely primarily possible for 1536 Diabetologia (2014) 57:1528–1541”
BackgroundMechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates
De León, D. D., & Stanley, C. A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0368 · Cited by 199
“Interestingly, heterozygous gain-of-function mutations in KCNJ11 cause transient or permanent neonatal diabetes”
BackgroundThe diagnosis and management of monogenic diabetes in children and adolescents
Rubio-Cabezas, O., Hattersley, A. T., Njølstad, P. R., Mlynarski, W., Ellard, S., White, N., Chi, D. V., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12192 · Cited by 196
“with associated neurological features (7, 54, 55) in”
InfluentialSelf-citationCardiac K channels in health and disease
KANE, G., LIU, X., YAMADA, S., OLSON, T., & TERZIC, A. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.02.026 · Cited by 200
Precision medicine in the management of type 2 diabetes
Gloyn, A. L., & Drucker, D. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30052-4 · Cited by 183
Self-citationNeonatal diabetes mellitus: a disease linked to multiple mechanisms
Polak, M., & Cavé, H. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-12 · Cited by 197
Monogenic diabetes: a gateway to precision medicine in diabetes
Zhang, H., Colclough, K., Gloyn, A. L., & Pollin, T. I. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142244 · Cited by 188
“Bonnefond A, et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.”
BackgroundInfluentialSelf-citationRelapsing diabetes can result from moderately activating mutations in KCNJ11
Gloyn, A. L., Reimann, F., Girard, C., Edghill, E. L., Proks, P., Pearson, E. R., Temple, I. K., Mackay, D. J. G., Shield, J. P. H., Freedenberg, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi086 · Cited by 197
Self-citationFunctional analysis of a structural model of the ATP‐binding site of the KATP channel Kir6.2 subunit
Antcliff, J. F., Haider, S., Proks, P., Sansom, M. S., & Ashcroft, F. M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600487 · Cited by 187
“Naturally occurring mutations at residues F35 (to V or A) and E322 (to K, which would be expected to disrupt the adjacent E321-R32 ion pair) cause permanent neonatal diabetes mellitus (PNDM) in humans (Sagen et al, 2004; Vaxillaire et al, 2004).”
BackgroundMethodInfluentialSelf-citationVaxillaire, M., Populaire, C., Busiah, K., Cavé, H., Gloyn, A. L., Hattersley, A. T., Czernichow, P., Froguel, P., & Polak, M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2719 · Cited by 186
Self-citationDe Franco, E., Saint‐Martin, C., Brusgaard, K., Knight Johnson, A. E., Aguilar‐Bryan, L., Bowman, P., Arnoux, J., Larsen, A. R., Sanyoura, M., Greeley, S. A. W., et al. (2020) · Human Mutation · doi:10.1002/humu.23995 · Cited by 174
Self-citationEdghill, E. L., Bingham, C., Slingerland, A. S., Minton, J. A. L., Noordam, C., Ellard, S., & Hattersley, A. T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01999.x · Cited by 174
Self-citationBowman, P., Sulen, Å., Barbetti, F., Beltrand, J., Svalastoga, P., Codner, E., Tessmann, E. H., Juliusson, P. B., Skrivarhaug, T., Pearson, E. R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30106-2 · Cited by 175
Self-citationHeterozygous ABCC8 mutations are a cause of MODY
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., Hattersley, A. T., & Ellard, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2319-x · Cited by 177
Self-citationMolecular structure of human KATP in complex with ATP and ADP
Lee, K. P. K., Chen, J., & MacKinnon, R. (2017) · eLife · doi:10.7554/elife.32481 · Cited by 176
Diabetes and Insulin Secretion
Koster, J. C., Permutt, M. A., & Nichols, C. G. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3065 · Cited by 175
KATPChannels and Cardiovascular Disease: Suddenly a Syndrome
Nichols, C. G., Singh, G. K., & Grange, D. K. (2013) · Circulation Research · doi:10.1161/circresaha.112.300514 · Cited by 171
“2 gain-of-function clearly revealed the potential for such gain-of-function mutations to cause neonatal diabetes mellitus(156) and led to the subsequent demonstration that such mutations are causal in human neonatal diabetes.(157) In parallel studies, we have explored the potential for Kir6.”
BackgroundMcTaggart, J. S., Clark, R. H., & Ashcroft, F. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.191767 · Cited by 169
“2 mutations causing ND impair channel inhibition by ATP (Gloyn et al. 2004; reviewed by Ashcroft, C© 2010 The Authors.”
Self-citationAhlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Rare and Common Genetic Events in Type 2 Diabetes: What Should Biologists Know?
Bonnefond, A., & Froguel, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.020 · Cited by 163
“mutations in this genewere subsequently shown to causemonogenic neonatal diabetes mellitus (Gloyn et al., 2004) as well as MODY-13 (Bonnefond et al.”
BackgroundABCC8 and ABCC9: ABC transporters that regulate K+ channels
Bryan, J., Muñoz, A., Zhang, X., Düfer, M., Drews, G., Krippeit-Drews, P., & Aguilar-Bryan, L. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0116-z · Cited by 164
Sesti, G., Laratta, E., Cardellini, M., Andreozzi, F., Del Guerra, S., Irace, C., Gnasso, A., Grupillo, M., Lauro, R., Hribal, M. L., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2323 · Cited by 157
“Loss-of-function polymorphisms in KCNJ11havebeenassociatedwithfamilialhyperinsulinemic hypoglycemia of infancy (11, 12), whereas gain-of-function polymorphisms have been associated with permanent neonatal diabetes ( 13 ) and classical form of type 2 diabetes (14– 25).”
BackgroundBonnefond, A., Unnikrishnan, R., Doria, A., Vaxillaire, M., Kulkarni, R., Mohan, V., Trischitta, V., & Froguel, P. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00421-w · Cited by 188
Gloyn, A. L., Diatloff-Zito, C., Edghill, E. L., Bellanné-Chantelot, C., Nivot, S., Coutant, R., Ellard, S., Hattersley, A. T., & Robert, J. J. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201629 · Cited by 159
“2 subunit of the pancreatic beta-cell ATP-sensitive potassium (K ATP ) channel have recently been described as a common and important cause of neonatal diabetes”
BackgroundSelf-citationMaturity onset diabetes of the young: identification and diagnosis
McDonald, T. J., & Ellard, S. (2013) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563213483458 · Cited by 152
Self-citation
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.